Literature DB >> 16632873

Neurogenic pain and steroid synthesis in the spinal cord.

Christine Patte-Mensah1, Cherkaouia Kibaly, Domitille Boudard, Véronique Schaeffer, Aurélie Béglé, Simona Saredi, Laurence Meyer, Ayikoe G Mensah-Nyagan.   

Abstract

The spinal cord (SC) is a biosynthetic center for neurosteroids, including pregnenolone (PREG), progesterone (PROG), and 3alpha/5alpha-tetrahydroprogesterone (3alpha/5alpha-THP). In particular, an active form of cytochrome P450 sidechain cleavage (P450scc) has been localized in sensory networks of the rat SC dorsal horn (DH). P450scc is the key enzyme catalyzing the conversion of cholesterol (CHOL) into PREG, the rate-limiting step in the biosynthesis of all classes of steroids. To determine whether neurosteroidogenesis might be involved in the pivotal role played by the DH in nociception, effects of neurogenic pain provoked by sciatic nerve ligature were investigated on P450scc expression, cellular distribution, and activity in the SC. P450scc mRNA concentration was threefold higher in the DH of neuropathic rats than in controls. The nerve ligature also increased the density of P450sccpositive neuronal perykarya and fibers in the ipsilateral DH. Incubation of spinal tissue homogenates with [3H]CHOL revealed that the amount of newly synthesized [3H]PREG from [3H]CHOLwas 80% higher in the DH of neuropathic rats. Radioimmunoassays showed an increase of PREG and 3alpha/5alpha-THP concentrations in neuropathic rat DH. The upregulation of PREG and 3alpha/5alpha-THP biosynthesis might be involved in endogenous mechanisms triggered by neuropathic rats to cope with the chronic pain state. 3alpha/5alpha-THP formation from PREG can also generate PROG, which decreases sensitivity to pain and protects nerve cells against degeneration. Because apoptotic cell death has been demonstrated in the DH during neuropathic pain, activation of neurosteroidogenesis in spinal tissues might also be correlated to the neuroprotective role of steroids in the SC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632873     DOI: 10.1385/jmn:28:1:17

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  160 in total

1.  Structure and sexual dimorphic expression of a liver-specific rat 3 beta-hydroxysteroid dehydrogenase/isomerase.

Authors:  H F Zhao; E Rheáume; C Trudel; J Couët; F Labrie; J Simard
Journal:  Endocrinology       Date:  1990-12       Impact factor: 4.736

2.  Steroidogenic enzyme gene expression in the human brain.

Authors:  Lu Yu; Damian G Romero; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2002-04-25       Impact factor: 4.102

3.  Rat cholesterol side-chain cleavage cytochrome P-450 (P-450scc) gene. Structure and regulation by cAMP in vitro.

Authors:  R B Oonk; K L Parker; J L Gibson; J S Richards
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

Review 4.  The induction of pain: an integrative review.

Authors:  M J Millan
Journal:  Prog Neurobiol       Date:  1999-01       Impact factor: 11.685

5.  Characterization of the substrate binding site in rat liver 3alpha-hydroxysteroid/dihydrodiol dehydrogenase. The roles of tryptophans in ligand binding and protein fluorescence.

Authors:  J M Jez; B P Schlegel; T M Penning
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

6.  Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury.

Authors:  L Guth; Z Zhang; E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 expression.

Authors:  D B Hales
Journal:  Endocrinology       Date:  1992-11       Impact factor: 4.736

8.  Characterization of rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase cDNAs and differential tissue-specific expression of the corresponding mRNAs in steroidogenic and peripheral tissues.

Authors:  H F Zhao; C Labrie; J Simard; Y de Launoit; C Trudel; C Martel; E Rhéaume; E Dupont; V Luu-The; G Pelletier
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

9.  Pregnenolone and its sulfate ester in the rat brain.

Authors:  C Corpéchot; M Synguelakis; S Talha; M Axelson; J Sjövall; R Vihko; E E Baulieu; P Robel
Journal:  Brain Res       Date:  1983-06-27       Impact factor: 3.252

10.  Ontogeny of expression of the genes for steroidogenic enzymes P450 side-chain cleavage, 3 beta-hydroxysteroid dehydrogenase, P450 17 alpha-hydroxylase/C17-20 lyase, and P450 aromatase in fetal mouse gonads.

Authors:  T L Greco; A H Payne
Journal:  Endocrinology       Date:  1994-07       Impact factor: 4.736

View more
  18 in total

Review 1.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

2.  Elevated Neurosteroids in the Lateral Thalamus Relieve Neuropathic Pain in Rats with Spared Nerve Injury.

Authors:  Meng Zhang; Jia Liu; Meng-Meng Zhou; Honghai Wu; Yanning Hou; Yun-Feng Li; Yuxin Yin; Lemin Zheng; Feng-Yu Liu; Ming Yi; You Wan
Journal:  Neurosci Bull       Date:  2016-06-21       Impact factor: 5.203

3.  Role of the neurosteroid allopregnanolone in the hyperalgesic behavior induced by painful nerve injury in rats.

Authors:  Takashi Kawano; Tomohiro Soga; Haidong Chi; Satoru Eguchi; Fumimoto Yamazaki; Naoko Kumagai; Masataka Yokoyama
Journal:  J Anesth       Date:  2011-08-31       Impact factor: 2.078

4.  Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice.

Authors:  Paolo Magnani; Anita Conforti; Elisabetta Zanolin; Marta Marzotto; Paolo Bellavite
Journal:  Psychopharmacology (Berl)       Date:  2010-04-20       Impact factor: 4.530

Review 5.  The DABBEC phenotyping system: towards a mechanistic understanding of CP/CPPS.

Authors:  Stephen A Allsop; Derek J Erstad; Karolina Brook; Salman F Bhai; Jeffrey M Cohen; Jordan D Dimitrakoff
Journal:  Nat Rev Urol       Date:  2011-01-18       Impact factor: 14.432

Review 6.  Allopregnanolone and Progesterone in Experimental Neuropathic Pain: Former and New Insights with a Translational Perspective.

Authors:  Susana Laura González; Laurence Meyer; María Celeste Raggio; Omar Taleb; María Florencia Coronel; Christine Patte-Mensah; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Neurobiol       Date:  2018-09-05       Impact factor: 5.046

Review 7.  Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship.

Authors:  Amandine Grimm; Yun-An Lim; Ayikoe Guy Mensah-Nyagan; Jürgen Götz; Anne Eckert
Journal:  Mol Neurobiol       Date:  2012-06-08       Impact factor: 5.590

8.  Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical.

Authors:  Liliane J Dableh; James L Henry
Journal:  J Pain Res       Date:  2011-04-05       Impact factor: 3.133

9.  Comparative Analysis of Gelsemine and Gelsemium sempervirens Activity on Neurosteroid Allopregnanolone Formation in the Spinal Cord and Limbic System.

Authors:  Christine Venard; Naoual Boujedaini; Ayikoe Guy Mensah-Nyagan; Christine Patte-Mensah
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

10.  Koumine enhances spinal cord 3α-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain.

Authors:  Hong-Qiang Qiu; Ying Xu; Gui-Lin Jin; Jian Yang; Ming Liu; Su-Ping Li; Chang-Xi Yu
Journal:  Mol Pain       Date:  2015-08-09       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.